Helicobacter pylori gastritis in HIV-infected patients: a review.
BACKGROUND
The risk factors for acquiring Helicobacter pylori and Human Immunodeficiency Virus (HIV) infections are different: H. pylori is transmitted by gastro- or fecal-oral routes and is associated with low socioeconomic conditions, while HIV is transmitted through sexual intercourse, infected body fluids, and transplacentally. If the host responses to these infections were independent, the prevalence of H. pylori should be similar in HIV-infected and non-infected patients. Yet, several studies have detected a lower prevalence of H. pylori in patients with HIV infection, whereas other studies found either no differences or greater rates of H. pylori infection in HIV-positive subjects.


OBJECTIVE
To review studies that addressed the issue of these two simultaneous infections and attempt to determine whether reliable conclusions can be drawn from this corpus of often contrasting evidence.


METHODS
Electronic literature search for relevant publications, followed by manual search of additional citations from extracted articles.


RESULTS
The initial search yielded 44 publications; after excluding case reports, reviews, narrowly focused articles, and duplicate reports, there remained 29 articles, which are the corpus of this review. With one exception, all studies reported higher rates of H. pylori infection in HIV-negative subjects. Five studies also examined the CD4 lymphocyte counts and found an inverse correlation between the degree of immunosuppression and the prevalence of active H. pylori infection.


CONCLUSIONS
Current evidence suggests that it is likely that H. pylori needs a functional immune system to successfully and persistently colonize the human gastric mucosa.
Miraca Life Sciences Research Institute, Irving, TX, USA.
Daniel T
DT
Nevin
Christopher J
CJ
Morgan
David Y
DY
Graham
Robert M
RM
Genta
D018791:CD4 Lymphocyte Count; D005753:Gastric Mucosa / Q000382:microbiology*; D005756:Gastritis / Q000453:epidemiology* / Q000276:immunology / Q000382:microbiology; D015658:HIV Infections / Q000150:complications*; D006679:HIV Seropositivity / Q000150:complications; D016481:Helicobacter Infections / Q000453:epidemiology* / Q000276:immunology / Q000382:microbiology; D016480:Helicobacter pylori / Q000276:immunology*; D006801:Humans; D016867:Immunocompromised Host; D015995:Prevalence; D012307:Risk Factors
AIDS; Epidemiology; HIV; Helicobacter pylori; immune response; immunocompromised host